464
Participants
Start Date
June 23, 2021
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
AboBoNT-A
AbobotulinumtoxinA for injection: 500 Unit vial. Dose: 900 Units (3.6 mL)
OnaBoNT-A
OnabotulinumtoxinA for injection: 200 Unit vial. Dose: 360 Units (3.6 mL)
New York University, New York
Weill Cornell Medicine Clinical and Translational Science Center, New York
Montefiore Medical Center, The Bronx
North Suffolk Neurology, Port Jefferson
Stony Brook University Medical Center, Stony Brook
Sunnyview Rehabilitation Hospital, Schenectady
Hôpital d'Instruction des Armées Laveran, Marseille
University of Pittsburgh Medical Center (UPMC), Pittsburgh
Penn State Health Physical Medicine and Rehabilitation - Neurology, Hershey
Centre Hospitalier de Saint Amand Montrond, Saint-Amand-Montrond
Aether Medicine, Wayne
MossRehab - Einstein Medical Center, Elkins Park
MedStar National Rehabilitation Network, Columbia
Carilion Clinic Institute of Orthopaedics and Neurosciences, Roanoke
University of Alabama, Birmingham
Centre de Perharidy, Roscoff
Emory University of School of Medicine, Atlanta
Hopital de Rangueil, Toulouse
Hôpital Pellegrin CHU Bordeaux, Bordeaux
First Choice Neurology, Boca Raton
James A Haley Veterans Hospital, Tampa
University of South Florida Health-Morsani Center for Advanced Healthcare, Tampa
Hôpital Pontchaillou (CHU Rennes), Rennes
Pole Saint Helier, Rennes
The Vanderbilt Clinic, Nashville
Siskin Hospital for Rehabilitation - Neurology, Chattanooga
Hopital Sud, Échirolles
University of Louisville, Louisville
Hôpital Saint-Jacques (CHU Nantes), Nantes
Cleveland Clinic - Neurological Institute, Cleveland
Fort Wayne Neurological Center, Fort Wayne
William Beaumont Hospital, Dearborn
Beaumont Hospital, Grosse Pointe, Grosse Pointe
Michigan Center of Medical Research, Grosse Pointe
Medical Rehabilitation Group, PC, Grand Blanc
Centre Les Capucins, Angers
Mary Free Bed Rehabilitation Hospital, Grand Rapids
Medical College of Wisconsin - Froedtert Hospital, Milwaukee
Mayo Clinic, Rochester
Centre Hospitalier de Saint-Amand-les-Eaux, Saint-Amand-les-Eaux
Hopitaux Universitaires De Strasbourg, Strasbourg
Hopital Henry Gabrielle (HCL), Saint-Genis-Laval
LSU Healthcare network, New Orleans
Hopital Fernand Widal, Paris
Texas Institute for Neurological Disorders, Sherman
University of Texas Southwestern, Dallas
TIRR Memorial Hermann Research Center, Houston
UT Health San Antonio, San Antonio
University of Utah School of Medicine, Salt Lake City
HonorHealth Scottsdale Osborn Medical Center, Scottsdale
Movement Disorders Center of Arizona, Scottsdale
The University of Arizona, Tucson
Hôpital Jean Bernard (CHU Poitiers), Poitiers
Wr-Crcn, Llc, Las Vegas
University of California Los Angeles, Los Angeles
Rancho Los Amigos National Rehabilitation Center (RLANRC) - Neurology, Downey
Southland Neurologic Institute, Long Beach
Loma Linda University Health Care, Loma Linda
Parkinson's & Movement Disorders Institute, Fountain Valley
Neuro-Pain Medical Center, Fresno
Hawaii Pacific Neuroscience, Honolulu
Swedish Neuroscience Institute, Seattle
Hasbani And Hasbani Medical Group, New Haven
Ki Health Partners LLC D/B/A New England Institute for Clinical Research, Stamford
Shirley Ryan Ability Lab, Chicago
Kansas City Bone and Joint Clinic, P.A. (KCBJ) - Overland Pa, Overland Park
UMass Memorial Medical Center - University Campus, Worcester
Rusk Rehabilitation Center, Columbia
Cooper University Health Care, Cherry Hill
Lawson Health Research Institute, London
Moncton Hospital, Moncton
Genge Partners, Montreal
Victoria General Hospital, Victoria
Hopital Archet (CHU de Nice), Nice
Centre Mutualiste de Rééducation et de Réadaptation Fonction, Ploemeur
University of Puerto Rico, Santurce
Lead Sponsor
Ipsen
INDUSTRY